Literature DB >> 8630664

The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene.

H E Montgomery1, P Clarkson, O M Nwose, D P Mikailidis, I A Jagroop, C Dollery, J Moult, F Benhizia, J Deanfield, M Jubb, M World, J R McEwan, A Winder, S Humphries.   

Abstract

We have investigated the effects of chronic physical training and acute intensive exercise on plasma fibrinogen levels and the relationship of these responses to beta-fibrinogen G-453-A polymorphism genotype. One hundred fifty-six male British Army recruits were studied at the start of their 10-week basic training, which emphasizes physical fitness. Cohorts were restudied between 0.5 and 5 days after a major 2-day strenuous military exercise (ME) undertaken in their final week of training. Changes in fibrinogen concentration were adjusted for the effects of age, body mass index, and smoking history. Compared with baseline values, fibrinogen concentrations were significantly lower (11.9%, P=.04) at day 5 after ME, consistent with the beneficial effect of training. However, they were higher on days 1 through 3 after ME (suggesting an "acute-phase" response to strenuous exercise) and were maximal on days 1 and 2 (27.2%, P<.001 and 37.1%, P<.001 respectively). Fibrinogen genotype was available in 149 individuals. As expected from previous studies, men with one or more fibrinogen gene A-453 alleles had plasma fibrinogen concentration slightly but significantly higher at baseline (4.5%, P=.11). During the acute-phase response (days 2 and 3), however, the degree of rise was strongly related to the presence of the A allele, being 26.7+/-5.4% (mean+/-SE), 36.5+/-11.0%, and 89.2+/-30.7 for the GG, GA, and AA genotypes, respectively (P=.01). These results confirm that chronic exercise training lowers plasma fibrinogen levels, that intensive exercise generates an acute-phase rise in levels, and that this acute response is strongly influenced by the G/A polymorphism of the beta-fibrinogen gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630664     DOI: 10.1161/01.atv.16.3.386

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

1.  Very late drug-eluting stent thrombosis post-exercise myocardial perfusion SPECT.

Authors:  A Dos Santos; J D Peirano; M J Bastianello; R O Calviño
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.

Authors:  A Tybjaerg-Hansen; B Agerholm-Larsen; S E Humphries; S Abildgaard; P Schnohr; B G Nordestgaard
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

3.  Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.

Authors:  D J Byrne; I A Jagroop; H E Montgomery; M Thomas; D P Mikhailidis; N G Milton; A F Winder
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Cortical bone resorption during exercise is interleukin-6 genotype-dependent.

Authors:  Sukhbir S Dhamrait; Laurence James; David J Brull; Saul Myerson; Emma Hawe; Dudley J Pennell; Michael World; Stephen E Humphries; Fares Haddad; Hugh E Montgomery
Journal:  Eur J Appl Physiol       Date:  2002-12-24       Impact factor: 3.078

Review 5.  Fibrinogen and coronary risk.

Authors:  W Koenig
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

6.  Effects of exercise on systemic inflammatory, coagulatory, and cardiac autonomic parameters in an inhalational exposure study.

Authors:  Aneesh Donde; Hofer Wong; Jessica Frelinger; Karron Power; John R Balmes; Mehrdad Arjomandi
Journal:  J Occup Environ Med       Date:  2012-04       Impact factor: 2.162

Review 7.  Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease.

Authors:  Christopher J Womack; Paul R Nagelkirk; Adam M Coughlin
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

8.  Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.

Authors:  Anne M Joseph; Stephen S Hecht; Sharon E Murphy; Harry Lando; Steven G Carmella; Myron Gross; Robin Bliss; Chap T Le; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2008-03       Impact factor: 4.244

9.  Altered arterial stiffness and subendocardial viability ratio in young healthy light smokers after acute exercise.

Authors:  Robert J Doonan; Patrick Scheffler; Alice Yu; Giordano Egiziano; Andrew Mutter; Simon Bacon; Franco Carli; Marios E Daskalopoulos; Stella S Daskalopoulou
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

10.  Training-induced changes in clotting parameters of athletic horses.

Authors:  Giuseppe Piccione; Marilena Bazzano; Claudia Giannetto; Simona Marafioti; Francesco Fazio
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.